Prolia
FDA Panel: Long-Used Osteoporosis Drug Too Risky »
"March 7, 2013 -- An FDA panel voted to stop recommending calcitonin salmon for the treatment of osteoporosis in women who are at least five years past menopause.
The committee voted 12-9 against continued marketing of the drug, citing"...
Read the FDA Panel: Long-Used Osteoporosis Drug Too Risky article »
Prolia
CONTRAINDICATIONS
Hypocalcemia
Pre-existing hypocalcemia must be corrected prior to initiating therapy with Prolia [see WARNINGS AND PRECAUTIONS].
Pregnancy
Prolia may cause fetal harm when administered to a pregnant woman. In utero denosumab exposure in cynomolgus monkeys resulted in increased fetal loss, stillbirths, and postnatal mortality, along with evidence of absent lymph nodes, abnormal bone growth and decreased neonatal growth. Prolia is contraindicated in women who are pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus [see Use in Specific Populations].
Hypersensitivity
Prolia is contraindicated in patients with a history of systemic hypersensitivity to any component of the product. Reactions have included facial swelling and urticaria [see ADVERSE REACTIONS].
Last reviewed on RxList: 6/15/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Prolia Information
Prolia - User Reviews
Prolia User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Here is a collection of user reviews for the medication Prolia sorted by most helpful.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Healthy Bones
Get tips and advances in treatment.
Updated & New
